| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |